Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study - Sharma, Rubina; Holtzman, Noa G.; Pusic, Iskra; Cutler, Corey; Treister, Nathaniel; Mehta, Rohtesh S.; Alousi, Amin S.; Vigneswaran, Nadarajah; Javaid, Ayesha; Boksa, Francis; Mody, Drashty P.; Costa-da-Silva, Ana C.; et al. (Blood advances, 2025)
Keywords: Adult; Aged; Chronic Disease; Female; Fibrosis - drug therapy; Graft vs Host Disease - drug therapy; Graft vs Host Disease - etiology; Graft vs Host Disease - metabolism; Graft vs Host Disease - pathology; Hematology; Humans; Inflammation - drug therapy; Inflammation - etiology; Inflammation - pathology; Interleukin-17 - metabolism; Male; Middle Aged; Mouth Mucosa - drug effects; Mouth Mucosa - metabolism; Mouth Mucosa - pathology; Protein Kinase Inhibitors - therapeutic use; rho-Associated Kinases - antagonists & inhibitors; Transplantation